Abstract: Systems and methods are provided for monitoring a patient's health is provided. The system includes a monitoring device configured to monitor one or more health parameters of the patient, wherein the monitoring device includes a sensing unit configured to receive the signals pertaining to the one or more health parameters, wherein the sensing unit includes one or more sensors configured to receive signals through non-physical contact with the patient. The system further includes a memory configured to store data pertaining to the signals, and a processor configured to analyze the data using pre-determined information and programmed artificial intelligence.

Abstract: A phase balancing system includes a load forecasting module, a phase unbalance identification module and a demand response module. The load forecasting module determines a load forecast for the distribution system for the period of interest and the phase unbalance identification module determines voltage unbalance on the distribution system for the period of interest. The demand response module estimates an available demand response on the distribution system for the period of interest and allocates an optimized demand response from the available demand response to minimize the voltage unbalance on the distribution system for the period of interest.

Abstract: A phase balancing system includes a load forecasting module, a phase unbalance identification module and a demand response module. The load forecasting module determines a load forecast for the distribution system for the period of interest and the phase unbalance identification module determines voltage unbalance on the distribution system for the period of interest. The demand response module estimates an available demand response on the distribution system for the period of interest and allocates an optimized demand response from the available demand response to minimize the voltage unbalance on the distribution system for the period of interest.

Abstract: A synergistic combination of pravastatin and aspirin is provided which is formed of 40 mg pravastatin and 81 mg or higher of aspirin, preferably 81 mg aspirin or 325 mg of aspirin. A method for preventing, inhibiting or reducing risk of onset of cardiovascular events or cerebrovascular events employing such synergistic combination is also provided.